{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T15:57:28Z","timestamp":1765727848021},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1097\/md.0000000000011682","type":"journal-article","created":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T20:52:58Z","timestamp":1533243178000},"page":"e11682","source":"Crossref","is-referenced-by-count":2,"title":["Comparative effectiveness of pharmacological treatments for patients with diarrhea-predominant irritable bowel syndrome"],"prefix":"10.1097","volume":"97","author":[{"given":"Ling","family":"Yue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tai-Chun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-Wei","family":"She","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-72-20210226","doi-asserted-by":"crossref","first-page":"1393.e5","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel disorders","volume":"150","author":"Lacy","year":"2016","journal-title":"Gastroenterology"},{"key":"R2-72-20210226","first-page":"71","article-title":"The epidemiology of irritable bowel syndrome","volume":"6","author":"Canavan","year":"2014","journal-title":"Clin Epidemiol"},{"key":"R3-72-20210226","doi-asserted-by":"crossref","first-page":"712.e4","DOI":"10.1016\/j.cgh.2012.02.029","article-title":"Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis","volume":"10","author":"Lovell","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R4-72-20210226","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12955-017-0611-2","article-title":"Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea","volume":"15","author":"Buono","year":"2017","journal-title":"Health Qual Life Outcomes"},{"key":"R5-72-20210226","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.tips.2010.04.008","article-title":"Current and emerging therapies in irritable bowel syndrome: from pathophysiology to treatment","volume":"31","author":"Chang","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"R6-72-20210226","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1757-4749-2-3","article-title":"Current insights in to the pathophysiology of Irritable Bowel Syndrome","volume":"2","author":"Karantanos","year":"2010","journal-title":"Gut Pathog"},{"key":"R7-72-20210226","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.3748\/wjg.v20.i10.2456","article-title":"Irritable bowel syndrome: emerging paradigm in pathophysiology","volume":"20","author":"Lee","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R8-72-20210226","doi-asserted-by":"crossref","first-page":"h701","DOI":"10.1136\/bmj.h701","article-title":"Irritable bowel syndrome in adults in primary care: summary of updated NICE guidance","volume":"350","author":"Hookway","year":"2015","journal-title":"BMJ"},{"key":"R9-72-20210226","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1056\/NEJMra1607547","article-title":"Irritable bowel syndrome","volume":"376","author":"Ford","year":"2017","journal-title":"N Engl J Med"},{"key":"R10-72-20210226","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.14309\/00000434-200901001-00002","article-title":"An evidence-based position statement on the management of irritable bowel syndrome","volume":"104","author":"Brandt","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R11-72-20210226","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1365-2036.2008.03633.x","article-title":"Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome","volume":"27","author":"Vahedi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"R12-72-20210226","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/13543784.2018.1442434","article-title":"Advancements in drug development for diarrhea-predominant irritable bowel syndrome","volume":"27","author":"Dothel","year":"2018","journal-title":"Expert Opin Investig Drugs"},{"key":"R13-72-20210226","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/CEG.S29023","article-title":"Targeted therapies for diarrhea-predominant irritable bowel syndrome","volume":"5","author":"Olden","year":"2012","journal-title":"Clin Exp Gastroenterol"},{"key":"R14-72-20210226","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/ajg.2014.187","article-title":"American college of gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation","volume":"109","author":"Ford","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R15-72-20210226","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1046\/j.1365-2036.1999.00678.x","article-title":"Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients","volume":"13","author":"Jones","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"R16-72-20210226","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa1505180","article-title":"Eluxadoline for irritable bowel syndrome with diarrhea","volume":"374","author":"Lembo","year":"2016","journal-title":"N Engl J Med"},{"key":"R17-72-20210226","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1004409","article-title":"Rifaximin therapy for patients with irritable bowel syndrome without constipation","volume":"364","author":"Pimentel","year":"2011","journal-title":"N Engl J Med"},{"key":"R18-72-20210226","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1053\/j.gastro.2016.08.003","article-title":"Repeat treatment with rifaximin is safe and effective in patients with diarrhea-predominant irritable bowel syndrome","volume":"151","author":"Lembo","year":"2016","journal-title":"Gastroenterology"},{"key":"R19-72-20210226","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/apt.12735","article-title":"Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials","volume":"39","author":"Schoenfeld","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"R20-72-20210226","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"R21-72-20210226","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/ijcp.12128","article-title":"The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study","volume":"67","author":"de Roest","year":"2013","journal-title":"Int J Clin Pract"},{"key":"R22-72-20210226","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1440-1746.2009.06015.x","article-title":"Simple diagnostic approach to childhood fecal retention using the Leech score and Bristol stool form scale in medical practice","volume":"25","author":"Koh","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"R24-72-20210226","doi-asserted-by":"crossref","first-page":"j3932","DOI":"10.1136\/bmj.j3932","article-title":"Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples","volume":"358","author":"Riley","year":"2017","journal-title":"BMJ"},{"key":"R25-72-20210226","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol Bull"},{"key":"R26-72-20210226","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods","volume":"15","author":"R\u00fccker","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"R27-72-20210226","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2288-13-35","article-title":"A graphical tool for locating inconsistency in network meta-analyses","volume":"13","author":"Krahn","year":"2013","journal-title":"BMC Med Res Methodol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000011682","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:19:15Z","timestamp":1620962355000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201808030-00072"}},"subtitle":["Protocol of a systematic review and network meta-analysis"],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":26,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000011682","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}